By Denny Jacob
ReShape Lifesciences received approval for a PMA supplement for its Lap-Band 2.0 FLEX from the Food and Drug Administration.
The approval is expected to be a growth catalyst for the weight loss and metabolic health solutions company's Lap-Band franchise, said Chief Executive Paul Hickey. He added that the company is preparing for its U.S. product launch of the latest iteration of the Lap-Band.
The FDA-approved Lap-Band System provides minimally invasive, long-term treatment of obesity, said ReShape.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
12-12-23 1630ET